SinoMab BioScience Limited (3681) 📈: отчетность и дивиденды за 2024

Reports

IFRS

Reporting Annual Quarterly

	2019	2020	2021	2022	2023
Финансовый отчет	link	link	link	link	link

Capitalization

IFRS

Reporting Annual Quarterly

	2017	2018	2019	2020	2021	2022	2023	LTM	5 year average	CAGR 5
Капитализация, млрд ¥			4.27	3.52	3.51	2.2	1.69	1.5
Выручка, млрд ¥					0.0259		0.0014	0.0014
Чистая прибыль, млрд ¥	-0.048	-0.0836	-0.2763	-0.1226	-0.2882	-0.2509	-0.2431	-0.2431
EV, млрд ¥		0.0188	2.76	2.77			1.84	1.84
EBIT, млрд ¥	-0.0396	-0.0548	-0.2759	-0.1226	-0.3059	-0.2286
EBITDA, млрд ¥	-0.0383	-0.0531	-0.2674	-0.1202	-0.2824	-0.2218		-0.2512
Баланс стоимость, млрд ¥	-0.051	0.0274	1.13	0.987	0.6802	0.4499	0.2956	0.2956
FCF, млрд ¥	-0.041	-0.0496	-0.2648	-0.2337	-0.1471	-0.3664	-0.2377	-0.2377
Операционный денежный поток, млрд ¥	-0.0402	-0.0468	-0.2225	-0.1413	-0.1471	-0.2654	-0.1338	-0.1338
Операционная прибыль, млрд ¥	-0.0396	-0.0548	-0.2759	-0.1627	-0.3059	-0.2418	-0.2296	-0.2296
Операционные расходы, млрд ¥	0.0396	0.0548	0.2759	0.1627	0.3318	0.2286	0.2309	0.2309
CAPEX, млрд ¥	0.000823	0.0027	0.0423	0.076	0.1982	0.0295	0.1039	0.1039

	2016Q4	2017Q1	2017Q2	2017Q4	2018Q1	2018Q2	2018Q4	2019Q1	2019Q2	2019Q4	2020Q2	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q4	5 quarters average	CAGR 5
Капитализация, млрд ¥										4.27	3.57	3.26		3.58		2.9		2.21		1.89		1.89	1.31
Выручка, млрд ¥																0.0259						0.0013
Чистая прибыль, млрд ¥														-0.1144	-0.0869	-0.1738	-0.0719	-0.1438	-0.0702	-0.1404	-0.067	-0.1241	-0.0545
EV, млрд ¥											2.67	2.51										1.75	1.84
EBIT, млрд ¥													-0.0614	-0.0614	-0.0915	-0.0915	-0.058	-0.058	-0.0715	-0.0715	-0.0547	-0.0506
EBITDA, млрд ¥	-0.0096	-0.0096	-0.0096	-0.0133	-0.0133	-0.0133	-0.0668	-0.0668	-0.0668
Баланс стоимость, млрд ¥									0.1974	1.13	1.1	0.987		0.8036		0.6802		0.5688		0.5096		0.3759	0.2956
FCF, млрд ¥	-0.0103	-0.0103	-0.0103	-0.0124	-0.0124	-0.0124	-0.0662	-0.0662	-0.0662
Операционный денежный поток, млрд ¥													-0.0444	-0.0444	-0.0291	-0.0291	-0.0728	-0.0728	-0.0775	-0.0775	-0.0314	-0.029
Операционная прибыль, млрд ¥								-0.069	-0.069	-0.2289	-0.0793	-0.0401		-0.1102		-0.1678		-0.1385		-0.1353		-0.1211
CAPEX, млрд ¥													0.0338	0.0338	0.0653	0.0653	0.0303	0.0303	0.047	0.047	0.0306	0.0283

	5 quarters average	CAGR 5

Cash flow Cash flow quarterly Assets

Balance sheet

IFRS

Reporting Annual Quarterly

	2017	2018	2019	2020	2021	2022	2023	LTM	5 year average	CAGR 5
Наличность, млрд ¥	0.0661	0.0415	1.2	0.8104	0.563	0.3053	0.2037	0.2037
Short Term Investments ¥	0.0468			0.0931		0.0269	0.031	0.031
Total Receivables ¥	0.000259
Total Current Assets ¥	0.1268	0.0503	1.22	0.9344	0.5957	0.3948	0.2702	0.2702
Чистые активы, млрд ¥	0.0347	0.0384	0.0422	0.1459	0.3562	0.429	0.4471	0.4858
Активы, млрд ¥	0.1616	0.0888	1.28	1.13	1.04	0.8903	0.8478	0.8478
Short Term Debt ¥	0.0468	0.01		0.005		0.0304	0.0666	0.0666
Long Term Debt ¥		0.033	0.0203	0.0555	0.1938	0.2749	0.3248	0.3248
Задолженность, млрд ¥	0.2126	0.0614	0.1522	0.1425	0.3614	0.4404	0.5522	0.5522
Чистый долг, млрд ¥	0.1459	0.0188	-1.15	-0.7499			0.1877	0.1877
Долг, млрд ¥		0.0603	0.0536	0.0605			0.3914	0.3572
Interest income ¥	0.0123	0.0282	0.000319	0.0173	0.0167	0.0104	0.0062
Расходы на обслуживание долга ¥		0.003	0.0023	0.0024	0.0058	0.0282	0.0066	0.0066
Чист. проц. доходы, млрд ¥	-0.0029	-0.0029	0.000655	0.0149	0.0109	0.0046	-0.000408	0.0068
Амортизация, млрд ¥	0.0013	0.0017	0.0085
Себестоимость, млрд ¥	0.000117	0.000743					0.000943	0.000943

	2016Q4	2017Q1	2017Q2	2017Q4	2018Q1	2018Q2	2018Q4	2019Q1	2019Q2	2019Q4	2020Q2	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q4	5 quarters average	CAGR 5
Наличность, млрд ¥									0.1964	1.2	1.04	0.8104		0.6431		0.563		0.3676		0.3457		0.2651	0.2037
Short Term Investments ¥											0.0779	0.0931		0.0502				0.0402		0.0305		0.0293	0.031
Total Current Assets ¥														0.7357	0.5957	0.5957	0.448	0.448	0.4471	0.4471	0.3435	0.3179	0.2702
Чистые активы, млрд ¥													0.233	0.233	0.3562	0.3562	0.3717	0.3717	0.4858	0.4858	0.5203	0.4815
Активы, млрд ¥									0.2469	1.28	1.22	1.13		1.04		1.04		0.9221		1.01		0.8397	0.8478
Short Term Debt ¥									0.01		0.0779	0.005								0.0304			0.0666
Long Term Debt ¥										0.0203	0.0559	0.0555		0.1205		0.1938		0.2131		0.2384		0.3021	0.3248
Задолженность, млрд ¥									0.0495	0.1522	0.1175	0.1425		0.2361		0.3614		0.3534		0.4988		0.4639	0.5522
Чистый долг, млрд ¥								-0.1511	-0.1511	-1.15	-0.9027	-0.7499										0.0421	0.1877
Долг, млрд ¥											0.1338	0.0605											0.3914
Interest income ¥									0.0013	0.001	0.0015	0.0016		0.0042		0.0059		0.0053		0.005		0.0032
Расходы на обслуживание долга ¥			0.00074	0.000758	0.000758	0.000758	0.000585	0.000585	0.000585									0.0295		0.0323		0.0185
Чист. проц. доходы, млрд ¥																0.0059		0.0057		0.0048		0.0032
Амортизация, млрд ¥	0.000313	0.000313	0.000313	0.000429	0.000429	0.000429	0.0021	0.0021	0.0021
Себестоимость, млрд ¥																						0.000873

	5 quarters average	CAGR 5

Share

IFRS

Reporting Annual Quarterly

	2016	2017	2018	2019	2020	2021	2022	2023	2024	LTM	5 year average	CAGR 5
EPS			-0.0831	-0.2746	-0.1218	-0.2864	-0.2424	-0.2349		-0.2349
Цена акции ао				3.54	4.6	2.86	1.81	1.68	1.1	1.1
Число акций ао, млн	1006.24	1006.24	836.65	1006.24	1006.24	1006.24	1034.92	1034.92		1034.92
FCF/акцию		-0.0408	-0.0593	-0.2631	-0.2322	-0.1462	-0.354	-0.2297		-0.2297

	2016Q4	2017Q1	2017Q2	2017Q4	2018Q1	2018Q2	2018Q4	2019Q1	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	5 quarters average	CAGR 5
EPS															-0.1727		-0.1429		-0.1288		-0.1199
Цена акции ао														3.23	2.88	2.55	2.2	1.96	1.83	2	1.83	1.44	1.26
Число акций ао, млн									836.65	1006.24	1006.24	1006.24	1006.24		1006.24		1006.24		1034.92		1034.92		1034.92
FCF/акцию	-0.0102	-0.0102	-0.0102	-0.0123	-0.0123	-0.0123	-0.0791	-0.0791	-0.0791

	5 quarters average	CAGR 5

Efficiency

IFRS

Reporting Annual Quarterly

	2017	2018	2019	2020	2021	2022	2023	2024	LTM	Industry average	5 year average	CAGR 5
ROE, %	94.16	-305.08	-24.41	-12.42	-42.37	-49.89	-65.22		-65.22	8.15
ROA, %	-29.68	-94.14	-21.51	-10.85	-27.67	-28.81	-27.97		-27.97	5.11
ROS, %					-1112.16		-17810.33	-17810.33	-17810.33	7.36
ROCE, %	77.71	-199.95	-24.37	-12.42	-44.96	-31.54				5.48
Рентаб EBITDA, %					-1089.7				-6.42	6.06
Чистая рентаб, %					-1112.16		-17810.33		-17810.33	7.37
Operation Margin, %					-1180.32		-16818.68	-16818.68	-16818.68	9.85
Доходность FCF, %			-6.2	-6.65	-4.19	-18.88	-14.09

	2019Q1	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q4	2023Q2	2023Q4	Industry average	5 quarters average	CAGR 5
ROE, %		-34.99	-20.31	-7.32	-4.23	-14.24	-25.55	-25.28	-27.55	-60.11	-18.44	8.15
ROA, %		-27.98	-17.91	-6.62	-3.7	-11	-16.68	-15.59	-13.92	-29.56	-6.43	5.11
ROS, %							-670.67			-9823.88		7.36
ROCE, %	-34.94	-34.94		-4.13	-3.62	-7.64	-13.45	-10.2	-14.03	-7.22		5.48
Чистая рентаб, %							-670.67			-9823.88		7.37
Operation Margin, %							-647.74			-9589.3		9.85

	Industry average	5 quarters average	CAGR 5

Coefficients

IFRS

Reporting Annual Quarterly

	2017	2018	2019	2020	2021	2022	2023	2024	LTM	Industry average	5 year average	CAGR 5
P/E			-15.45	-28.67	-12.18	-7.74	-6.94			22.50
P/BV			3.77	3.56	5.16	3.74	5.61		5.61	2.99
P/S					135.51		1213.88		1213.88	9.92
P/FCF			-16.12	-15.04	-23.88	-5.3	-7.1	-6.31	-6.31	6.18
E/P			-0.0647	-0.0349	-0.0821	-0.1293	-0.1441	-0.1621	-0.1621	0.04
EV/EBITDA		-0.3533	-10.31	-23.01					-5.89	-5.04
EV/Ebit			-8.53	-25.7				0	0
EV/S							1351.42	1351.42	1351.42	46.67
EV/FCF			-8.89	-11.84			-7.76	-7.76	-7.76	16.02
Debt/EBITDA			-0.2005	-0.5031			-1.42	-1.42	-1.42	0.72
Netdebt/Ebitda	-3.8	-0.3533	4.29	6.24			0	-0.7473	-0.7473	-0.64
Debt/Ratio			0.0418	0.0535			0.4617	0.4213	0.4213	0.10
Debt/Equity			0.0474	0.0613			1.32	0.7353	0.7353	0.96
Debt/Net Income			-0.1941	-0.4932			-1.61	-1.47	-1.47	1.14
Бета							-1.84	-1.08	-1.08	1.00
Индекс Альтмана							1.22	2.24	2.24	5.87

	2019Q1	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q4	2023Q2	2023Q4	Industry average	5 quarters average	CAGR 5
P/E			-18.57	-44.18	-77.99	-31.27	-16.67	-15.38	-13.5	-14.1	-23.96	22.50
P/BV			3.77	3.23	3.3	4.45	4.26	3.89	3.72	4.54	5.61	2.99
P/S							111.8			1351.61		9.92
E/P			-0.0539	-0.0226	-0.0128	-0.032	-0.06	-0.065	-0.0741	-0.0709	-0.0417	0.04
EV/Ebit										-34.55
EV/S										1384.91		46.67
Netdebt/Ebitda	2.26	2.26										-0.64
Debt/Ratio				0.1095	0.0535						0.4617	0.10
Debt/Equity				0.1212	0.0613						1.32	0.96
Debt/Net Income				-1.66	-1.45							1.14

	Industry average	5 quarters average	CAGR 5

Dividends

IFRS

Reporting Annual

	LTM	Industry average	5 year average	CAGR 5
Дивиденд	0
Див доход, ао, %	0	2.64
Дивиденды / прибыль, %	0	18.57

	Industry average	5 quarters average	CAGR 5

	Industry average	5 quarters average	CAGR 5

Other

IFRS

Reporting Annual Quarterly

	2021	2023	CAGR 5
ebit_margin	-1180.32
Персонал, чел		282

	2023Q2	CAGR 5
ebit_margin	-4008.21

	CAGR 5

Investing Port

HKEX: 3681 - SinoMab BioScience Limited

Reporting SinoMab BioScience Limited

Reports

Capitalization

Balance sheet

Share

Efficiency

Coefficients

Dividends

Pay for your subscription

Other